Days Inventory is also known as Days Sales of Inventory (DSI). Amgen's Average Total Inventories for the
three
months ended in Sep. 2023 was $5,002 Mil. Amgen's Cost of Goods Sold for the
three
months ended in Sep. 2023 was $1,806 Mil.
Hence, Amgen's Days Inventory for the
three
months ended in Sep. 2023 was 252.73.
The historical rank and industry rank for Amgen's Days Inventory or its related term are showing as below:
AMGN'
s Days Inventory Range Over the Past 10 Years
Min: 219.41 Med: 242.04 Max: 314.33
Current: 254.48
During the past 13 years, Amgen's highest Days Inventory was 314.33. The lowest was 219.41. And the median was 242.04.
AMGN's Days Inventory is ranked worse than 78.61% of 991
companies
in the Drug Manufacturers industry
Industry Median: 154.72
vs AMGN: 254.48
Amgen's Days Inventory
declined
from Sep. 2022 (267.52) to Sep. 2023 (252.73).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Amgen's Inventory Turnover for the
three
months ended in Sep. 2023 was 0.36.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Amgen's Inventory-to-Revenue for the
three
months ended in Sep. 2023 was 0.72.
Amgen Days Inventory Historical Data
The historical data trend for Amgen's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Amgen Annual Data
Trend
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Days Inventory
256.95
273.33
221.55
225.62
256.86
Amgen Quarterly Data
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Days Inventory
267.52
252.99
263.70
251.38
252.73
Competitive Comparison
For the Drug Manufacturers - General subindustry, Amgen's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amgen Days Inventory Distribution
For the Drug Manufacturers industry and Healthcare sector, Amgen's Days Inventory distribution charts can be found below:
* The bar in red indicates where Amgen's Days Inventory falls into.
Amgen Days Inventory Calculation
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Amgen's Days Inventory for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amgen (NAS:AMGN) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Amgen's Inventory Turnover for the
three
months ended in Sep. 2023 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Amgen's Inventory to Revenue for the
three
months ended in Sep. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Amgen Days Inventory Related Terms
Thank you for viewing the detailed overview of Amgen's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amjevita (biosimilar Humira).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
3.04(1.14%) Volume: 2,499,855 4:00PM EST
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
AMGN has been successfully added to your 